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Blood brain barrier (BBB) cells play key roles in the physiology and pathology of the central nervous 
system (CNS). BBB dysfunction is implicated in many neurodegenerative diseases, including 
Alzheimer’s disease (AD). The BBB consists of capillary endothelial cells, pericytes encircling the 
endothelium and surrounding astrocytes extending their processes towards it. Although there have 
been many attempts to develop in vitro BBB models, the complex interaction between these cell 
types makes it extremely difficult to determine their individual contribution to neurotoxicity in vivo. 
Thus, we developed and optimised an in vitro multicellular co-culture model within the Kirkstall 
Quasi Vivo System. The main aim was to determine the optimal environment to culture human brain 
primary endothelial cells, pericytes and astrocytes whilst maintaining cellular communication without 
formation of a barrier in order to assess the contribution of each cell type to the overall response. 
As a proof of concept for the present system, the effects of amyloid-beta 25-35 peptide (Aβ25-35), a 
hallmark of AD, were explored. This multicellular system will be a valuable tool for future studies on the 
specific roles of individual BBB cell type (while making connection with each other through medium) in 
CNS disorders as well as in cytotoxicity tests.
The blood brain barrier (BBB) is a specialised structure separating the central nervous system (CNS) from the 
peripheral blood circulation. It is crucial for maintaining the homeostasis of the brain microenvironment and 
prevention of entry of toxic substances into the CNS1,2.
The BBB consists of brain microvascular endothelial cells interconnected by tight junctions, which are one of 
the most important features of the BBB. Although brain endothelial cells are responsible for formation of tight 
junctions, both pericytes and astrocytes have also been shown to participate in their formation3–7, and thus are 
critical for maintaining normal BBB physiology and function as a barrier.
Despite the fact that several BBB barrier models have been created, most lack the ability to study individual 
BBB cell types separately, whilst maintaining communication between them. For instance, the function of peri-
cytes in the BBB formation is still unknown, but has been described as essential to maintain BBB properties4,6,8–17. 
Although some BBB models include pericytes, these cells are usually not obtained from human brain. On the 
other hand, astrocytes are necessary to provide growth factors, nutrients and oxygen in the BBB3,8,10,18–25, now 
being widely used to improve the in vitro endothelial cell culture2,3,20,26,27. However, pericytes and astrocytes are 
not studied separately while communicating with each other and also with endothelial cells.
Comprehension of the factors that allow paracrine signalling when cells are not forming a barrier, but are able 
to communicate amongst them, could help in the design and improvement of future BBB models using human 
primary cells, identification of therapeutics targets for BBB integrity preservation as well as early detection of 
toxic effects over each specific cell type conforming the BBB.
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BBB dysfunction has been linked to Alzheimer’s disease (AD)28,29. One of the pathological hallmarks of AD is 
extracellular deposition of senile plaques of amyloid β (Aβ) peptides in the brain, but the mechanisms by which 
Aβ peptide leads to AD are not yet fully understood. Different Aβ protein subtypes are known to cause inflamma-
tion and changes to BBB function. At high concentrations (nanomolar to micromolar), Aβ causes neurotoxicity 
and cell death30. Among the Aβ fragments studied so far, the Aβ 25-35(Aβ25-35), corresponds to the biologically 
active fragment of the full-length Aβ1-42 peptide that retains full toxicity31. A clear breakdown of the BBB bar-
rier was demonstrated in vivo by Evans-blue extravasation in rat brain only 30 min after Aβ25-35 infusion into 
the right common carotid artery32. However, the mechanism of action of this peptide on each specific cell type 
shaping the BBB is still unknown.
Thus, in the present study, we set out to develop an in vitro multicellular system by culturing the human pri-
mary cell types, brain primary endothelial cells (HBECs), pericytes (HBVPs) and astrocytes (HAs) within the 
Kirkstall Quasi Vivo 500 system (QV500). This system allows multiple cell types to be cultured in interconnected 
chambers under flow whilst sharing the same culture medium. Although the different cell types are not in close 
contact, this model enables cell-cell communication through the sharing of the medium, resembling better physi-
ological interactions when they are exposed to different compounds without formation of a true barrier. The main 
aims of the present study were i) to develop the best culture and maintenance conditions for these cell types (an 
improved culture medium, appropriate scaffolding systems and the optimal flow rate) in order to create a multi-
cellullar co-culture flow system and ii) to check the feasibility of this multicellular system for toxicity screening 
on each cell type separately. As a proof of concept to achieve the second aim, we harnessed this system to explore 
the possible specific toxic effects of Aβ25-35 on brain endothelial cells, astrocytes and pericytes, while maintained 
cell-cell communication without formation of a true barrier.
Results
Determination of cell phenotypes by immunocytochemistry. To investigate if the human primary cells 
exhibited altered or expected phenotypes at early passages, specific antibodies, which have been used widely to con-
firm identity of these cell types were selected. As shown in Fig. 1, immunocytochemical studies showed that human 
astrocytes were able to selectively express glial fibrillary acidic protein (GFAP) (Fig. 1A), pericytes expressed α-actin 
fibres (Fig. 1B), and endothelial cells expressed CD31 (Fig. 1C), showing their expected morphology corresponding 
to one of the most characteristic features studied for each cell type. In addition, the ability of endothelial cells to form 
tight junctions under static conditions was confirmed by antibody labelling of the tight junction marker, zonula 
occludens (ZO1), thereby demonstrating they were able to express this marker even in the absence of flow (Fig. 1D).
Figure 1. Representative immunocytochemistry image obtained using a Zeiss LSM700 or LSM 510 confocal 
microscope. (A) Atrocytes stained with GFAP, (B) pericytes stained with α-actin, (C) endothelial cells stained 
with CD31 and (D) endothelial cells forming tight junctions (zonula occludens, ZO1) (white arrows). Scale 
bar = 50 μm. In the right, representative images of the three human primary cell lines – astrocytes (a), pericytes 
(b) and endothelial cells (c) – cultured independently at early stages (passage 2) are shown. Images were taken 
from an optical microscope (Nikon Eclipse TS 100) at 20× augmentation.
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BBB Multicellular co-culture system. To construct a BBB multicellular co-culture system, we used 
HBECs, HBVPs and HAs. Firstly, we determined the best scaffolding and optimal medium for these cell types 
individually. The original media available for each cell type were improved and tested in order to find the best mix 
to culture and maintain successfully the three cell types under the same conditions. When the improved medium 
was established, flow was applied to each cell type individually and to the three cell types together. Control cells 
were cultured in parallel under identical conditions without flow. These experiments were carried out for the first 
time within the Kirkstall Quasi Vivo system. We have tried to characterize the optimal flow rate for each cell type 
and the best culture conditions in order to create the optimal environment to develop an in vitro dynamic BBB 
model using transwells in the future. The morphological phenotypes of the cell types cultured independently at 
early stages (passage 2) at low magnification levels (20x) and close to reaching confluence are shown in Fig. 1a–c.
Determination of optimal flow rate. After the optimal medium was achieved and the expected features 
for each cell type confirmed, the effect of flow for each cell type compared to the static conditions was evaluated. 
To determine the highest flow rate that the cells could sustain, experiments with each cell type within the QV500 
chambers (Fig. 2B) were carried out in triplicate and compared to the results obtained for each cell type under 
static conditions. Different flow rates were used to determine the optimum shear stress for all three cell types, up 
to 300 µl/min (0, 50, 100 and 300 µl/min). These values correspond to shear forces of 0, 2 × 10−6, 2.9 × 10−6 and 
6.5 × 10−6 Pa, respectively. As expected, endothelial cells were able to survive at higher flow rates than 2.9 × 10−6 Pa, 
whereas astrocytes and pericytes died when the flow rate exceeded 2 × 10−6 Pa (data not shown). Thus, an opti-
mum flow rate of 50 µl/min for growing and maintaining all three cell types was chosen for all subsequent exper-
iments (Fig. 2A for schematic representation). This flow rate corresponds to wall shear stresses of 2 × 10−6 Pa 
(equivalent to 2 × 10−5 dynes cm−2) at the cell culture surface, and a flow speed of 2.6 × 10−7m/s. The ideal equi-
librium was reached for all 3 cell types under the same conditions. This provided advantage of interconnection 
within all three cell types as well as the continuous flow of improved medium through the chambers, therefore 
maintaining a crucial homogeneous environment for all BBB elements while keeping them separate and main-
taining their original individual features.
Multicellular co-culture system using different combinations of cells. In order to determine the 
importance of the culture of the 3 cell types alone or together, cells were cultured under flow separately (three 
replicates of each cell type inside the QV500 chambers, Fig. 3A–C) and one of each cell type inside every QV500 
chamber (Fig. 3D). The aims of these experiments were to determine the importance of the co-culture of the cells 
together, the importance of the use of the improved medium and the effect of flow on cell viability. As shown in 
Fig. 4, no statistically significant differences were observed when comparing the cell viability using MTT assay for 
each cell type alone (A) and together (B) when using a 50 µl/min flow rate after 72 h inside the QV500 system in 
triplicate and compared to static conditions (represented as 100%). However, a tendency of a higher viability of 
HBECs was observed when they were cultured in triplicate (Fig. 4A, one-way ANOVA, p = 0.07, n = 3). In fact, 
analysis of HBECs cultured alone in triplicate showed a significant viability improvement after 72 h under flow 
(percentage increase over control of 40.5% ± 15.5) when compared to static conditions (100%) (Student’s t test, 
p = 0.045, n = 3). The pattern for all the cells studied was the same when culturing cells separately or together 
under the flow.
Effects of Aβ25-35 on each cell type. Once the optimum cell culture and flow conditions had been estab-
lished using QV500 chambers, the cells seeded in the coated coverslips, further experiments were performed 
exploring the effect of Aβ25-35 on each cell type to get a proof of concept of the multicellular co-culture system. 
The design, procedure and analysis were the same as for the flow rate characterization, using only 50 µl/min at 
different treatment times (24 and 72 h) and always feeding the cells with the improved media (in the presence and 
absence of Aβ25-35, 20 μM).
Figure 2. Schematic representation of Quasi-Vivo QV500 system (Kirkstall Ltd) (A) and a real image of QV500 
system showing a single QV500 chamber connected to the reservoir containing cell culture media (B).
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The same viability was maintained after 24 h treatment with Aβ25-35 when compared to the control (in the 
absence of Aβ25-35), showing no perceivable effect of the compound under static conditions (Fig. 5A). However, 
as it is shown in Fig. 5B, Aβ25-35 treatment affected different cell lines in different ways under dynamic condi-
tions when compared with the non-treated controls (one-way ANOVA, F = 5.151, p = 0.0008, n = 3). In fact, 
Aβ25-35 affected the viability of pericytes after only 24 h of exposure in a negative way (58.5% ± 12.1), prompting 
Figure 3. Schematic representation of the different combinations of cells cultured inside the QV500 chambers 
when using Kirkstall QV500 interconnected chambers. Each independent diagram shows the three cell 
types cultured alone in triplicate (A–C): astrocytes (green), pericytes (orange) and endothelial cells (blue), 
respectively), or together (D): astrocytes, pericytes and endothelial cells). T: Tank (media reservoir), R: Rotor 
(peristaltic pump). Arrows show the direction of the applied flow rate.
Figure 4. Cell viability measured by MTT assay comparing the three cell types under flow (50 µl/min) 
individually and in triplicate after 72 h inside the QV500 chambers (A) and the three cell types under flow 
(50 µl/min) together (one replicate of each cell time per experiment) (B). Results in both cases were normalized 
using the static conditions-control (black dotted line, 100%) from 3 to 8 independent experiments. No 
significant differences were observed.
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a significant 41.5% decrease in viability (Fig. 5B), compared with control, expressed as 100% (One-way ANOVA, 
Post Hoc Tukey, p = 0.02, n = 4). Endothelial cells showed an increase in cell viability (152.6% ± 89.0) when com-
pared with control, showing a significant 52.6% improvement (One-way ANOVA, Post Hoc Tukey, p = 0.02, 
n = 3). Under these conditions, astrocytes did not suffer any significant effect compared to control (101.5% ± 9.1; 
One-way ANOVA, Post Hoc Tukey, p = 0.8, n = 3).
Notably, after 72 h of Aβ25-35 treatment an effect on the viability of pericytes was only observed under static 
conditions (viability of 70.2% ± 23.9; One-way ANOVA, Tukey’s multiple comparison test, n = 3, p = 0.0029), 
whereas no effect of Aβ25-35 was shown in any other cells regardless of application of shear stress (101.9% ± 2 
for HBECs and 90.9% ± 41.3 for HAs, Fig. 5C,D). No statistically significant changes were obtained either when 
controls under the flow were compared to static controls (data not shown), as expected due to the aforementioned 
flow rate characterization (Fig. 4).
Discussion
Investigation of the dynamic metabolism and numerous roles of each of the diverse BBB components necessi-
tates development of a suitable in vitro system capable of determining the role of individual cell types separately 
to understand the contribution of each cell type to the overall response. During the last decade, there has been 
increasing interest in determining the basic design requirements for generating physiologically relevant in vitro 
systems33.
In the present study, we have constructed a simple multicellular co-culture system under flow within Kirkstall 
Quasi Vivo interconnected chambers using human primary brain endothelial cells, human brain vascular peri-
cytes and human brain astrocytes. The scaffolding system for each cell type and the optimum flow rate to culture 
Figure 5. Cell viability measured by MTT assay comparing the three cell types under static and dynamic 
conditions in the presence and the absence of Aβ25-35. HBECs (blue bars), pericytes (orange bars) and 
astrocytes (green bars) where treated with Aβ25-35 (20 µM) in static conditions during (A) 24 h and (B) 
72 h and under dynamic conditions (50 µl/min) inside the QV500 chambers during (C) 24 h and (D) 72 h 
and compared with control (absence of Aβ25-35 and represented as the black dotted line, 100%). Results are 
shown in percentage over control (100%) of 3 independent experiments. Significant differences in cell viability 
were obtained between Aβ25-35 treated and non treated cells when one-way ANOVA test (Tukey’s multiple 
comparison) was performed (*p < 0.05, **p < 0.01).
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and maintain the three cell types under the same conditions were established as a priority aim. The different 
flow rates applied showed that 2 × 10−5 dynes cm−2 was the optimum shear stress able to maintain the viability 
of all three cell types closest to that observed under static conditions. The BBB tight junction formation was not 
assessed by measuring transendothelial electrical resistance (TEER) of endothelial cells as we did not create a 
barrier model but a multicellular co-culture system for toxicological studies. However, we have determined the 
tight junction expressed using immunocytochemistry in order to ensure that the human brain primary endothe-
lial cells chosen for the study maintained their original features, and that they had not changed their morphology 
during passaging process.
The multi-compartmental modular Kirkstall Quasi Vivo system was chosen due to the multiple advantages 
of co-culturing different cell types in monolayers, thereby improving the cell function34. This milli-scaled system 
maintains the same protocols used in traditional static multi-wells as it has shape and dimensions similar to 
those of a classic 24-multiwell cell culture plate (13 mm diameter and 11 mm height)33. It allows chambers to be 
connected in series or parallel as required, and the main features of the system are the absence of air bubbles, high 
oxygen transport through convection, and the possibility of connecting additional chambers35. One of the main 
disadvantages of milli-scale methods is the difficulty to analyse the contribution of each cell type to the co-culture 
function. The design of the Kirkstall Quasi Vivo independent chambers abolish this disadvantage. This system 
has been previously used to create other organ-flow systems growing different cell types, and studied in detail by 
several authors33,35–39. The Quasi Vivo system has been shown to have low shear stress, a short time scale for test 
compound distribution, and sufficient oxygen availability at higher flow rates40.
Despite the fact that other systems have been developed, this is believed to be the first example of a mul-
ticellular system using BBB cells without forming a barrier, thereby allowing the study of each cell type sepa-
rately. Other models have been published, but their format and purpose are completely different. For instance, the 
model recently designed and developed by Brown and collaborators22 corresponds to a microfluidic system on a 
chip, which is able to determine the passage of different compounds through BBB model. Although these micro 
and nano-scaled systems are fashionable and may mimic physiological interactions between cells, these devices 
remain a niche research tool. As explained by Mattei and collegues33, they are not representative of a tissue/organ 
and cannot meaningfully predict in vivo physiology or pathophysiology. Our system allows use of different cells 
on each experiment and the option to observe the individual effect of compounds over each cell type. This allows 
pre-screening of different drugs, nanoparticles or the molecule of interest in a more realistic environment. The 
aim of this study was not to develop a barrier but to investigate the effect of different compounds or conditions 
over each specific cell type.
It is well known that astrocytes are not supposed to suffer shear stress in the brain. However, we aimed to eval-
uate their possible change in terms of viability when they were co-cultured under interstitial flow-like conditions, 
as has been proposed in the literature41,42. Although endothelial cell viability under flow was not highly significant 
(p = 0.04) compared to the static conditions, it was clearly improved (higher than a 53% increase of the viability), 
whereas astrocytes and pericytes remained unchanged. The same pattern was observed when a single cell type 
was placed inside Quasi Vivo chambers (Fig. 4A) and when the three cell types were placed in connecting cham-
bers (Fig. 4B). This suggests that the system is working as expected, and that astrocytes are also able to resist shear 
stress. This fact allowed us to co-culture endothelial cells, astrocytes and pericytes together under the same con-
ditions. It is important to point out that astrocytes would not be under shear effects in a BBB model even though 
they are exposed to interstitial flow. However, it was necessary in this study in order to enable communication 
between cell types without a direct contact.
There is increasing evidence that AD induces complex changes in barrier functions43, but the individual con-
tribution of these cell types in the disease mechanisms is not clear. Thus, one of the secondary aims of the present 
work was to explore the possible effects of Aβ25-35 fragment on BBB individual cell types under dynamic and 
static conditions as a proof of concept for this system. Aβ25-35 is the shortest biologically active fragment of 
full-length Aβ (1-42) that retains full toxicity31. Aβ25-35 was chosen as a proof of concept for this multicellular 
co-culture system because this peptide has been shown to produce membrane perforation, calcium increase and 
synaptotoxicity, and this fragment exhibited neurotrophic and neurotoxic activities similar to those of the (1-40) 
peptide44. The differences in terms of toxicity for different Aβ fragments have been already studied by other 
groups45.
Several studies have reported the cytotoxic effects of Aβ25-35 in different cell lines31,32,46,47. In fact, a recent 
study showed how cell viability was significantly decreased after exposure to 5, 10, 20 and 30 μM Aβ25-35 for 24 h, 
and reported that the half maximal inhibitory concentration (IC50) was 20 μM when using SH-SY5Y cells46. Thus, 
the chosen Aβ25-35 concentration for our preliminary experiments was 20 μM.
In the present study, pericytes were affected by Aβ25-35 exposure after only 24 h treatment under flow, 
whereas endothelial cells and astrocytes were not affected in the early stages of Aβ25-35 toxicity (Fig. 5B). This 
fact is in agreement with previous studies where cultured human brain pericytes alone were used to study the 
mechanisms of microvascular amyloid formation and cytotoxic effects of Aβ on perivascular cells48,49. This effect 
was not observed in a significant manner under static conditions (Fig. 5A). The degenerative effect that pericytes 
showed after 24 h treatment under a shear stress was observed after 72 h under static conditions (Fig. 5C), an 
effect that was completely abolished under flow (Fig. 5D). This result might suggest that an initial flow of 2 × 10−5 
dynes cm−2 is able to promote great differences following a specific treatment in early stages. It also suggests the 
possible compensatory effects that could be driven by co-culturing the three cell types together when a flow is 
applied, a fact that cannot be observed when cells were cultured in static terms (even though the same conditions 
were followed except the flow). In fact, after 72 h of co-culture under dynamic conditions, no negative or positive 
significant effect over any of the three cell type’s viability was observed, suggesting that both toxic and compen-
satory effects could be different when applying shear stress, and implying the possible importance of these shear 
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forces over this system containing a multicellular co-culture model. Moreover, it has been shown how the effect 
of Aβ25-35 is cell –type specific, in agreement with a previous report46.
In the present study, we did not explore the complex mechanism of AD pathogenesis which is beyond the scope 
this study. Although the mechanisms of Aβ25-35 are not well understood, previous studies have reported that it 
exerts the toxic effects by production of inflammatory cytokines, reducing glucose metabolism and inhibiting 
cytoprotective proteins50–52. We would expect that the concentration of paracrine signalling molecules close to 
the cells is affected by the flow rate, media volumes, the diffusion constant, cellular production and uptake rates, 
molecular half-life and adsorption onto the walls of the device. In the case of hydrophilic molecules such as Aβ25-
35 or cytokines, the latter factor is negligible as PDMS preferentially adsorbs small hydrophobic moieties53. Besides 
the fluid dynamics of the system, which is quite well-characterised33,34, to build a full picture of the signalling 
environment requires a combination of cellular output of signalling molecules including the response by the cells 
to the change to this environment. The total volume within the system will dilute concentrations; however typical 
signalling molecules such as cytokines have high production rates. It has been reported a production rate of 4 mol-
ecules per cell/s54, half-lifetimes of the order of 30 minutes) and very low equilibrium reaction constants (10 pM)55. 
Although beyond the scope of this investigation, understanding flow systems more broadly in this type of frame-
work combined with experimental models could help build a more detailed understanding of cellular behaviour.
Further research is needed in this field to explore the exact mechanism of action of Aβ25-35 on pericytes and 
determine if the observed decrease in cell viability could directly affect the permeability of the BBB and, in turn 
leading to BBB leakage (using a new BBB model with the formation of a barrier).
In conclusion, this multicellular co-culture system could become a useful tool for toxicity screening to evaluate 
the specific effects of neurotoxic, neuroinflammatory and neuroinfectious agents on each cell type separately and 
would provide improved conditions to develop a BBB dynamic model using human primary cells in the future.
Material and Methods
Immunocytochemistry. Briefly, the coverslips containing each specific cell type were washed twice in 0.1 M 
phosphate buffered saline (PBS, pH 7.6) and fixed with fresh 4% paraformaldehyde (PFA) for 10 minutes. The 
PFA was discarded and the coverslips were washed 3 times in PBS for 5 minutes each. The coverslips were placed 
into a 12- or 24-well plate and were re-suspended in 10% horse serum for 1 hour at room temperature. Primary 
antibody incubation was carried out for 2 hours at room temperature or overnight at 4 °C with gentle agitation. 
The primary antibodies used to stain HAs, and HBVPs were Glial Fibrillary Acidic Protein (GFAP) and α-actin 
respectively (both from Santa Cruz Biotechnology, UK, catalogue numbers sc-33673 and sc-32251, respectively). 
HBECs were identified by using primary antibodies against CD31 and Zonula Occludens (Rb anti ZO-1), both 
from Thermo Fisher, catalogue numbers PA5 16031 and 40–2200, respectively). All antibodies were used in a 
1:100 dilution except HBVPs and CD31, which were used in 1:300 and 1:40 dilutions, respectively. After incu-
bation with the primary antibody, the samples were washed in PBS for 3 × 5 min. The corresponding secondary 
antibody conjugated to Alexa Fluor (1:1000) or Cy3 (1:500) was added to the cells for 1 hour at room temperature 
with gentle agitation. Cells were washed in PBS for 3 × 5 min, and the coverslips were inverted onto a drop of 
mounting medium containing DAPI (Vectashield antifade mounting medium with DAPI, Vector Laboratories, 
UK) on a microscope slide, and stored at 4 °C. The immunostained cells were viewed under confocal (Zeiss 
LSM 700 inverted or Zeiss LSM 510 upright) or fluorescence (Zeiss Axiovision) microscopes using appropriate 
excitations for each fluorophore. All images were imported into ImageJ-Win64 program for minor adjustment of 
brightness and contrast, resizing or cropping and assembling into figures. After lettering, the layers were merged 
and the images were saved as TIFF files using Microsoft Office PowerPoint.
Human brain primary cells (astrocytes, pericytes and endothelial cells) culture. Human primary 
cells were purchased from available commercial firms, which are committed to the highest ethical and legal stand-
ards and approvals. Endothelial cells (CSC-C1503, passage 0) were obtained from Creative Bioarray (Creative 
Dynamics, Inc, UK), whereas astrocytes (1800-5) and pericytes (1200) were both obtained from ScienCell (UK), 
purchased through Caltag Medsystems (UK).
In all cases, cells were cultured in T75 flasks until 85–90% confluence (Fig. 1) to avoid possible cell differ-
entiation or inhibition processes. Human brain primary endothelial cells (HBECs) were cultured following 
the protocols of Patabendige and Abbott (2014) with minor modifications. Endothelial Cell Growth Medium 
MV2 (Promocell, UK) was used to feed HBECs every 2 days until the cells reached ~90% confluency. Astrocyte 
medium from primary human astrocyte (HA) culture (conditioned medium) was combined with endothelial cell 
medium as previously described by other groups56 in a 1/3 proportion. The medium was filtered using Millipore 
Express (PES) Membrane (pore size 0.22 μm, diameter 33 mm, sterile, γ-irradiated) and stored at −80 °C until 
use. HBECs and Human Brain Vascular Pericytes (HBVPs) conditioned media were also collected and stored in 
exactly the same way as described for astrocytes for further experiments of co-culture with “improved medium”.
Passage of cells was carried out by standard trypsinisation (SigmaAldrich, UK). After centrifugation, the pellet 
was re-suspended and cells counted using a haemocytometer. All flasks, plates and coverslips were coated before-
hand using collagen type I from rat tail (Sigma Aldrich, UK), following the protocol described elsewhere2. These 
cells were able to maintain their original phenotype and grow fast up to passage seven. However, cells were only 
used up to passage 5 in the present study. Both HAs and HBVPs were cultured with Dulbecco’s modified Eagle’s 
Medium/Ham’s Nutrient mixture F12 (DMEM) (Sigma Aldrich, UK), supplemented with 10% sterile filtered 
foetal bovine serum (FBS) of South American Origin (Labtech.com), 1% antibiotics (Penicillin – Streptomycin) 
and 1% L-Glutamine (Sigma Aldrich, UK).
The improved medium consisted of filtered conditioned medium obtained from all cell types and mixed with 
fresh medium. The final improved medium also contained a higher volume of fresh media (60%) than filtered 
media (40%). The 40% of filtered media consisted in equal parts of each cell line’s conditioned media. Final 
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volumes were variable depending on the experiment, but this proportion was always strictly maintained. Cells 
were supplemented with fresh improved medium every 3–4 days, depending on the requirements, until conflu-
ence was achieved. The trypsinisation process was carried out using the method as described previously.
Flasks, plates and coverslips used to culture HAs and HBVPs were coated with Poly-d-lysine hydrobromide 
(Sigma Aldrich, UK), following the steps described elsewhere2.
These cells were able to maintain their original phenotype and grow fast up to high number of passage, 
although were used for experiments at early stages (up to passage 5).
Co-culture of astrocytes, pericytes and endothelial cells using Kirkstall Quasi vivo (QV500) sys-
tem. After connecting all the components of the QV500 system as explained by the manufacturer (http://
www.kirkstall.com/why-quasi-vivo/), the system was sterilised with 70% ethanol by allowing the alcohol to pass 
through the system at a flow rate of 200 µl/min for 24 hours. The solvent was removed, the components dried 
and PBS was passed through the system to remove any ethanol residues. Finally, the system was flushed with 1% 
antibiotics (Penicillin – Streptomycin) in PBS for at least 24 hours to ensure sterility prior to the addition of cells. 
The QV500 system was assembled inside a class II cabinet and the coverslips carrying cells were placed in separate 
chambers (Fig. 2). Then, 1 ml of medium was added to each chamber with the cells facing up. The tank providing 
the cells with nutrients was supplemented with 30 ml of improved medium (Fig. 2B).
Combinations of cells were carried out to investigate the effect of a serial setup. Three replicates of a single 
cell type, (Fig. 3A–C) or the 3 cell types together (Fig. 3D) were cultured in order to place them inside QV500 
chambers (Fig. 2B) the previous day of the experiment. In this system, the three QV500 chambers are intercon-
nected and sharing the medium coming from the reservoir, which is gently pumped according to the desired 
flow rate impulse by the peristaltic pump (Fig. 2A for scheme). In order to increase the reproducibility of the 
results, the density of the cells used was always 105 per experiment for every cell type. This density was enough 
to form a monolayer of cells covering completely the coverslip after 24 h of culture. Cells were seeded using 
the correspondent scaffolding method (depending on the cell type) following the aforementioned protocol and 
optimized medium, and were placed in the incubator overnight to ensure the cells had successfully attached to 
the coverslips. The following day, cells were ready for the experiment inside the QV500 chambers. Coverslips 
containing cells in triplicate (Fig. 3A–C) or one of each cell type (Fig. 3D) were placed facing upwards, and flow 
was maintained for 72 h. Control and flow-treated cells were kept in the same incubator for the duration of the 
experiment. A flow rate ranging from 0–300 µl/min (0–6.5 × 10−6 Pa) was applied to the system. The calculations 
used to obtain shear and flow speed values are described in equations 1 and 2, respectively19.
µ= × . × + . ×− −Shear (Pa) Flow ( L/min) 1 8 10 1 1 10 (1)8 6
µ= × . × + . ×− −Flow Speed (m/s) flow ( L/min) 2 6 10 1 3 10 (2)9 7
The QV500 system with cells under a constant flow was placed in the incubator. Cells were maintained inside the 
model under flow for 72 hours. As a viability control, the model was replicated in static conditions using a con-
ventional 12 well plate, and placed in the same incubator at the same time. The impact of flow on cell viability was 
assessed by an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.
MTT cell viability assay. Static experiments were carried out without flow by culturing the cells inside 
12-well plates using the same protocol. Cells were incubated in the presence and absence of soluble Aβ25-35 
(20 μmol/L) for 24 and 72 h assessing the possible effect of a specific flow rate (50 µl/min, 2 × 10−5 dynes cm−2). 
After the required incubation time, all the cells in the coverslips were placed in 12-well plates and washed twice 
with PBS. MTT assay was carried out by adding 1 mg/ml solution of MTT (Sigma M5655) in DMEM/F-12, 
HEPES, no phenol red from Gibco (catalog number: 11039021) and adding 500 µl of the solution into each of the 
wells on the coverslips. Cells were incubated for 4 hours at 37 °C protected from light. Then, 350 µl of isopropanol 
was added to the cells with gentle pipetting up and down and shaking at 400 rpm for 20 mins to dissolve the crys-
tals formed. Finally, the liquid was transferred into a 96 well plate in triplicate for each condition and the optical 
density (OD) was measured on an IMark absorbance microplate reader (Bio-Rad, UK) with a test wavelength of 
570 nm, using isopropanol as blank.
Statistical analysis. All data are presented as mean ± SD of 3–6 independent experiments, being normally 
performed in triplicate. Data were analyzed by one-way ANOVA, with differences between groups assessed by 
Tukey’s post hoc tests. All graphs and analysis were performed using GraphPad Prism v6 software (GraphPad, San 
Diego, California). Statistical significance was determined when P < 0.05.
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